S23-103 Touchless Selection of Gene Modified Cell Therapies Through TRAC Intron Knockins Genetically modified cell therapies, such as CAR-T therapies, have revolutionized cancer treatments. Ansuman Satpathy Theodore Roth
S22-010 Supplementation with inosine improves CAR-T cell metabolism and anti-tumor effects Researchers at Stanford have developed a method of culture media supplementation with inosine during the chimeric antigen receptor (CAR)-T cell manufacturing process which can alter and enhance CAR-T cell metabolism and anti-tumor functions. Crystal Mackall Dorota Klysz Steven Feldman